Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9R5Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,705
Award facts
- Contract value 100% obligated
- $14,705.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,705.07 to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 28, 2026, for the supply of REXULTI 1 mg tablets in a 30-count package. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by January 29, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide. The delivery order reflects the company's ongoing capability to efficiently fulfill government contracts for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9R5Y?
SPE2DR26F9R5Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F9R5Y worth?
The government has obligated $14,705 on SPE2DR26F9R5Y.
Is contract SPE2DR26F9R5Y an order under another contract?
Yes. SPE2DR26F9R5Y is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R5Y competed?
The extent of competition for SPE2DR26F9R5Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award